Corteva, Inari settle lawsuit over seed patent dispute
In its lawsuit, Corteva accused Inari Agriculture Inc. of taking Corteva’s patent-protected seeds, making slight genetic modifications and preparing to commercialize them under its own name.
In its lawsuit, Corteva accused Inari Agriculture Inc. of taking Corteva’s patent-protected seeds, making slight genetic modifications and preparing to commercialize them under its own name.
The plaintiff fears that the BioBond product will cause confusion and reputation damage for it in the U.S., where it sells a product under the BioCote trademark.
Laws regarding privacy, data protection, and cybersecurity are evolving, and artificial intelligence is challenging established norms of intellectual property creation, protection, and enforcement.
A Boston-based biotech company with large operations in Indiana has closed on a $103 million funding raise, bringing its cumulative fundraising to more than a half-billion dollars for the eight-year-old company.
A Nevada-based biotech company is suing Eli Lilly and Co., saying the Indianapolis-based drugmaker is refusing to pay royalties on patented technology it claims is used in Lilly’s pending new treatment for Alzheimer’s disease.
A Texas jury this week awarded Purdue University $32.5 million in damages in its patent infringement lawsuit against an international microelectronics company.
A federal judge has overturned a $176.5 million jury verdict against Eli Lilly and Co., finding that the Indianapolis-based drugmaker did not infringe on the patents of a competitor in developing a treatment for migraine headaches.
Corteva Agriscience Inc. is suing a Massachusetts startup, saying the company has taken Corteva’s patent-protected seeds, made slight genetic modifications and is preparing to commercialize them under its own name.
Elizabeth Baumhart has been a practicing trademark attorney for about five years now. In that time, she’s learned to put a bold, underlined warning on every file notification email she sends to clients. The warning: Be on the lookout for scams.
A patent attorney with a history of deceitful misconduct has been suspended without automatic reinstatement after violating multiple Indiana Professional Conduct Rules related to a business he opened in Florida under an alias.
The rules that govern patent drawings deserve an overhaul.
Defendants in a multidistrict patent case that involved more than 200 attorneys and staff across 15 law firms, including an Indianapolis law firm, have been awarded a combined $15 million in attorney fees and expenses.
Do you or your clients have operations or sales in Russia? It is not a popular place to be doing business right now. The physical conflict in Ukraine has spread to economic and political countermeasures, including various private companies voluntarily withdrawing from the Russian market. But the Russian government is striking back at U.S. and other companies who are pulling out of the market by modifying the Russian intellectual property systems.
Purdue University’s Purdue Research Foundation is suing Google LLC over Android software that Purdue says incorporates patented technology for smartphones.
One of Europe’s largest chip makers wants a federal judge to order Purdue Research Foundation to turn over documents concerning two patents that are the focus of a different lawsuit.
The Supreme Court on Monday ruled that Congress erred when it set up a board to oversee patent disputes by failing to make the judges properly accountable to the president.
The COVID-19 pandemic killed millions worldwide and uprooted livelihoods and industries in the past year. But at least one industry has emerged relatively unscathed, if not stronger. Some Indiana intellectual property attorneys have seen an increase in patent requests and inventions during the pandemic as individuals utilized their creative skills while quarantining.
Amid all the news around the new year, you might have missed that the variety of changes to federal intellectual property laws, the Trademark Modernization Act (TMA) and the Copyright Alternative in Small-Claims Enforcement Act (CASE Act).
A final surprise for 2020 emerged from December’s marathon omnibus spending and COVID-19 relief negotiations. Congress included a trio of notable and hotly debated intellectual property measures in its multi-trillion-dollar spending and relief package which could fundamentally alter the manner in which intellectual property owners protect and enforce their rights.
Should SCOTUS fail to take up the matter now or fail to address broader issues and provide a more cogent framework for Section 101 patent eligibility in its determination, I expect the next round of significant news on the subject to be Congress stepping in and acting.